Nelson Hardiman managing partner Harry Nelson presented at the 13th Annual Family Office Investment Symposium where he discussed the four main buckets of potential life sciences investing, including 1) pharma/biotech, 2) medical devices, 3) neutraceuticals, supplements, and cosmeceuticals, and 4) clinical research and technology transfer.
Posted on February 27, 2018
Recent Posts
Healthcare from the Hot Bench: Non-Competes, Non-Solicitation, and No-Poach AgreementsReproductive Rights Attorney: This Is Why Right-Wing Interest Are Attempting To Ban MifepristoneHarry Nelson on Forbes News: Impact of the Alabama Supreme Court’s Frozen Embryo RulingCalifornia’s Corporate Healthcare Law, Practice of Medicine (CPOM)Harry Nelson interviewed regarding asthma inhaler switch coming in January